Meet Dr. Charles Chabert – Specialist Robotic/Keyhole & Laser Surgeon
Qualifications and accreditation
Dr Charles Chabert is the director of Laparoscopic Urology Australia, a consultant urological surgeon and Assistant Professor at Bond University, Gold Coast, Queensland, Australia. He currently holds clinical appointments at Pindara Private Hospital, John Flynn Private Hospital, The Wesley Hospital, Brisbane and Lismore Base Hospital.
Charles attended medical school at Aberdeen University where he was awarded a Bachelor of Medicine and Surgery (MBChB) with distinctions in surgery, anatomy and physiology. His post graduate training was initially in general surgery, culminating with an invitation to become a Member of the Royal College of Surgeons of Edinburgh (MRCS(Ed)).
Following this, Charles undertook advanced urological surgical training in NSW during which time he was awarded the Christopher Farrell prize and the George Schnitzler Award for best registrar of the year.
On completion of general urologic training, Charles undertook additional sub-specialized training in laparoscopic (keyhole surgery) urology mentored by one of Europe’s pioneering laparoscopic surgeons. Expertise in laparoscopic urological surgery was gained including laparoscopic nerve sparing radical prostatectomy; keyhole prostate surgery for prostate cancer. Whilst on this fellowship Charles also published and presented several papers relating to various aspects of prostate cancer surgery and treatment and reconstructive laparoscopic urology in international medical journals and urological conferences worldwide.
Following this, Charles was invited to become a Fellow of the Royal Australasian College of Surgeons (FRACS(Urol)).
Since this time Dr Charles Chabert has been dedicated to the provision of minimally invasive surgical treatment options for prostate conditions including laparosocpic radical prostatectomy (keyhole prostate removal) as well as Robotic assisted laparoscopic radical prostatectomy (robotic keyhole prostate removal) and GreenLight laser prostatectomy. Dr Chabert has established the first laparoscopic or keyhole prostatectomy service on the Gold Coast, QLD and the first same service in rural Australia in Lismore, NSW. At the time of writing Dr Chabert has a combined experience of over 500 cases of keyhole and robotic assisted keyhole prostate surgery with outcomes that are equivalent to those of large published international series. This includes low positive surgical margin rates, excellent urinary continence and potency. Dr Chabert is the only urologist on the Coast with a dedicated Fellowship in Keyhole surgery and the only surgeon offering Keyhole and Robotic assisted keyhole surgery.
Specialist GreenLight Laser Surgeon
Dr Chabert also established the first GreenLight laser prostatectomy (GLP) program in Queensland and is now one of only two recognized trainers in this technique in Australia. Dr Chabert was integral in the establishment of the GreenLight laser program at St. Vincent’s Private Hospital, Lismore which was the forth centre in Australia to acquire this technology and the first rural centre nationwide to commence a GLP program in June 2008. Dr Chabert has now performed over 500 cases, the outcomes of which have been presented at state, national and international meetings. He has also been an invited speaker at the Australian and New Zealand Urological Annual meeting in Perth 2010, to discuss GreenLight Laser surgery, and the forth Asia-pacific GreenLight Laser workshop 2010 at the Sydney Adventist Hospital.
A leader in Keyhole Urological Surgery
Dr Chabert performs robotic assisted laparoscopic radical prostatectomy at the Wesley Hospital, Brisbane and currently is one of only three surgeons in Queensland that are trained and qualified in laparoscopic (keyhole) and robotic assisted laparoscopic (keyhole) approaches.
Dr Chabert remains passionate about the delivery of high quality minimally invasive surgery for urological conditions. This journey will continue to evolve from its current platform as our understanding of disease grows and technology continues to develop.